Management of Persistent Hemoptysis

Initial Assessment and Severity Classification

Massive hemoptysis is defined as bleeding placing the patient at high risk for asphyxiation or exsanguination, with the rate of bleeding correlating more closely with mortality than total volume, according to the American College of Chest Physicians 1, 3
Immediately assess airway patency, hemodynamic stability, and oxygenation status as the first priority, as recommended by the American Thoracic Society 1
Two or more opacified lung quadrants on chest radiograph correlate with increased mortality risk, as reported by the American College of Radiology 1

Proceed directly to bronchial artery embolization (BAE) without delay, as delaying BAE significantly increases mortality, according to the Society of Interventional Radiology 1, 2
Intubate immediately with a single-lumen cuffed endotracheal tube to allow bronchoscopic suctioning and clot removal, as recommended by the American Society of Anesthesiologists 4, 1
BAE has immediate success rates of 73-99% in controlling bleeding, as over 90% of massive hemoptysis originates from systemic arterial supply, according to the American College of Cardiology 1, 3, 2

Obtain CT chest with IV contrast as the preferred initial diagnostic test to identify cause and location of bleeding, with diagnostic accuracy of 80-90%, as recommended by the American College of Radiology 1, 3, 2
CT is superior to bronchoscopy in identifying etiology, with a diagnostic yield of 77% vs 8%, according to the American Thoracic Society 2

Administer antibiotics for patients with at least mild hemoptysis, as bleeding may represent a pulmonary exacerbation, as recommended by the American Thoracic Society 5, 2
Stop NSAIDs immediately in patients with at least mild hemoptysis, as they impair platelet function and worsen bleeding, according to the American College of Gastroenterology 5, 2

Use bronchoscopy for both diagnostic and therapeutic purposes, providing information on anatomic site, side of bleeding, nature of source, and severity, with diagnostic yield of 70-80%, as recommended by the American College of Chest Physicians 4, 3
Bronchoscopic-guided topical hemostatic tamponade therapy using oxidized regenerated cellulose mesh immediately arrested hemoptysis in 98% of patients, according to the American Thoracic Society 4

External beam radiation therapy (EBRT) is recommended for non-massive hemoptysis in patients with unresectable lung cancer, with hemoptysis relief rates of 81-86%, as recommended by the American Society for Radiation Oncology 4, 3

Recurrence of bleeding occurs in 10-55% of cases after BAE, requiring close follow-up, according to the Society of Interventional Radiology 1, 3, 2
Higher recurrence rates are associated with chronic pulmonary aspergillomas, malignancy, and sarcoidosis, as reported by the American College of Chest Physicians 1